Invitae Divests Ciitizen Health Data Platform and Implements Further Cost Cuts

– Maintains Minority Equity Stake in Ciitizen – – Anticipated Total Cash Savings of Approximately $90-100 Million on an Annualized Basis – SAN FRANCISCO, Dec. 13, 2023 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical genetics company, today announced strategic changes to streamline…

Click here to view original post